Breaking News

Baxter Opens Singapore Biologics Facility

Will support the processing of ADVATE

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Baxter International Inc. has opened its first advanced recombinant biologic facility in Singapore, and plans to expand with a new recombinant protein processing suite. The establishment of the facility and new investment will have created 450 biopharma jobs in Singapore by 2015.   The current suite supports the processing of ADVATE [Antihemophilic Factor (Recombinant)], the company’s recombinant factor VIII (rFVIII) for the treatment of patients with hemophilia A. The second suite will initiall...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters